Egis today is among the Top50 foreign companies operating in Vietnam.

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. That is why we have been supporting the annual ’Scientific and Innovation Talent Recruitment Contest for Youth’ for decades. This year, Egis’ prize went to undergraduate student Hunor Sebők.

Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the second wave of the coronavirus pandemic as well.

Our Polish branch, Egis Polska, has been present on the market for 25 years and has made a tangible change in the country’s medical reality. Egis Polska introduces innovative medicines, including biological therapies, acts as a respected partner for the medical community, and is recognized as a valued employer, regularly awarded for creating a quality work environment.

On the occasion of the 25th anniversary of its establishment, KÖVET Association launched its ‘For a sustainable economy’ anniversary program and announced a tender for several categories, one of which was won by Egis on topic of environmental savings.